'Life-changing' neonatal charity's services saved
Leo's, based in north-east England, supports families' mental health and well-being through initiatives such as neonatal peer support, which matches parents with people who have experienced similar trauma.
It was facing an uncertain future because of fewer donations and grants.
The charity has partnered with law firm Slater and Gordon, which has committed funding. Leo's founder Lottie King said: "If it hadn't have been for them, our whole neonatal provision would have gone."
The money has saved the charity's neonatal peer support service.
"Our neonatal trauma service has proved a lifeline to so many parents and it would have been absolutely devastating if we had to close," Ms King said.
Ms King, who is from Yarm in Stockton, set up the charity in 2018 after one of her own twin boys was born prematurely and died a few hours after birth.
The story of how Lottie King set up Leo's charity
Since then, the charity has helped thousands of families across the region.
Senior associate at Slater and Gordon in Newcastle John Lowther said the firm was "delighted" to partner with the organisation.
"We are so pleased we can help them to continue their life-changing work," Mr Lowther added.
Follow BBC North East on X, Facebook, Nextdoor and Instagram. Send your story ideas here
Mum celebrates son's legacy on his 10th birthday
'I owe my life' to funding-hit neonatal charity
'First time I saw my baby I said goodbye'
Leo's Neonatal
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
5 days ago
Soccer star speaks out 2 months after collapsing on field mid-game
Angel City FC defender Savy King is speaking out and raising awareness about CPR, two months after she suddenly collapsed on the field during a May 9 match between Angel City and the Utah Royals. The National Women's Soccer League star had been celebrating a teammate's goal just moments before she collapsed and told "Good Morning America" she doesn't recall everything that happened at the time. "There's actually a lot that I don't remember," King said. "But I remember I wasn't feeling right and I remember I grabbed my leg because I was trying to distract myself from the fact that, like, I felt like I was gonna pass out. And then … I remember the medical staff coming onto the field." Both Angel City and Utah Royals team members gathered in a prayer circle while Angel City's medical staff responded to King for several minutes. King, 20, ended up getting rushed to the hospital while unresponsive, according to the Angel City FC medical team staff. "I'd never had, like, any medical history of anything, like, with my heart, even in injuries in general," King told "GMA." King's doctor said after multiple tests, they learned the pro athlete had a rare congenital heart abnormality and experienced a form of heart attack. Dr. Richard Kim is one of King's doctors and the director of congenital cardiac surgery at Cedars-Sinai in Los Angeles. "Savy was born with an anomalous left coronary artery," Kim explained. "The left coronary is the most important blood vessel in your heart, and when it's anomalous, it means that it's in a slightly different location than normal." Kim led a team of doctors who performed heart surgery to correct King's condition. "In Savy's case, we created a new pathway for the blood to get to the artery, so the blood goes into her blood vessel in pretty much a normal fashion," said Kim. "I think the first responders on the field did a fantastic job of resuscitating her before there was permanent damage." After undergoing surgery, King posted on Instagram, thanking the Angel City FC medical team, which includes head athletic trainer Hollie Walusz and Sarah Smith, vice president of medical and performance. Speaking with "GMA," the two recalled the moment King collapsed and their subsequent on-field efforts. "We made the decision then to start chest compressions while the AED was getting applied," Walusz recalled. "For it to happen on that night, in our home stadium, where we had our entire medical team there, it was incredible work of that group and the timing that … it actually happened to be able to have the outcome that we had," Smith added. King credits the medical team for saving her life. "They saved my life," said King. "That will stay with me forever in my heart, and just knowing that, like, I get to play in front of them too and see that they were a huge reason why I'm here is, like, I play for them too now." Both of King's mothers were by her side throughout the incident, and King said she wants them to know that she loves them. "They are everything to me," said King. "I wouldn't be here without them. I can't even continue talking about it, because ... there's not enough, like, anything I can give them. But the rest of my career, the rest of my life is for them." Although King is not yet cleared to return to competition, doctors say they are hopeful King can play again in the future. "I was just so happy that I was gonna be able to recover and be as normal and almost be like a Savy 2.0 now," King said when she learned of her prognosis. "So I'll be back, and I'll be better than ever." In the meantime, King is showing support for her team, attending practice this week for the first time since she collapsed. "Every time I see soccer, I wanna play," she said. "So it's obviously so hard to just watch and not be able to play. Even just watching games, it's awesome, just to have, like, a different perspective now that I can't play and just seeing a different part of the sport is really cool." She also encouraged everyone to learn CPR. "Anything can happen at any time," King said. "So just knowing how to do CPR, I think, is super important -- 'cause it can save a life, and it saved my life."
Yahoo
6 days ago
- Yahoo
LEO Pharma secures rights to Boehringer's Spevigo for $105m
Danish dermatology leader LEO Pharma has bought the rights to Boehringer Ingelheim's psoriasis drug Spevigo (spesolimab) for €90m ($105m), strengthening its portfolio ahead of a possible public listing in 2026. The transaction will see LEO gain the exclusive global licence for Spevigo, taking control of commercialisation and development rights. The full terms of the deal were not disclosed as both companies are privately owned, but LEO confirmed it is in line for milestone payments and royalties. The deal is expected to close in the second half of 2025. Spevigo is approved in the US, Japan, China and most European countries to treat generalised pustular psoriasis (GPP) flares, a rare but severe dermatological disease that can be fatal. It has also been approved in expanded indications in GPP in certain territories. LEO's new asset is a monoclonal antibody that blocks the activation of the interleukin-36 (IL-36) receptor - a key signalling pathway in the immune system implicated in the pathogenesis of several autoinflammatory diseases. Indeed, GPP may not be the ceiling for Spevigo – LEO said there is an 'opportunity to investigate the potential of Spevigo in additional skin conditions with high unmet medical need in which IL-36 is implicated'. LEO calls Spevigo 'the flagship dermatology product' of Boehringer Ingelheim, though the drug's sales have not been publicly disclosed. Comparing sales from other drugs is tricky because Spevigo is the only US Food and Drug Administration (FDA)-approved treatment specifically for GPP. Boehringer Ingelheim's head of human pharma Shashank Deshpande said: 'Spevigo holds a significant promise, and ensuring it reaches its full potential requires continued focus and expertise in medical dermatology. With over six decades of singular dedication to this field, LEO Pharma is exceptionally well-positioned to build on the strong foundation we've laid.' Adding Spevigo to its portfolio represents a strengthening of assets for dermatology specialist LEO. The Danish drugmaker has been building its pipeline amid reports it is planning an initial public offering (IPO) next year. Christophe Bourdon, who was appointed CEO in 2022 and tasked with turning the fortunes of the company around, has made no secret of public listing plans. In an interview with Bloomberg yesterday [14 July], Bourdon said market conditions and shareholders' wishes will decide the best timing for an IPO. The deal with Boehringer Ingelheim marks the second time LEO has signed a licensing agreement with a big pharma company in 2025. In January, Gilead Sciences offered a potential $1.7bn for LEO's preclinical STAT6 research programmes, which the dermatology company agreed to. As part of the deal, LEO received $250m in an upfront payment, boosting its cash on hand. "LEO Pharma secures rights to Boehringer's Spevigo for $105m" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Los Angeles Times
6 days ago
- Los Angeles Times
Is Waterless Beauty Better for Your Skin Barrier?
Waterless beauty and solid skincare are having a moment. From eco-driven wellness brands to dermatologist shelves, these concentrated, waterless formulas are redefining what it means to achieve healthy, resilient skin, both in appearance and function. But do they deliver on their promise of better barrier protection, gentler formulas, and more potent actives? Or are they just another fleeting trend? For the time-strapped but ingredient-savvy crowd, here's what really matters. Traditional skincare products are often more water than anything else, sometimes up to 80%. Waterless skincare skips water as a primary ingredient, allowing actives to shine in more concentrated forms. Think of solid cleansing bars, balms, and serums that pack a punch in a smaller, lighter package. Why does this matter for your skin barrier? Without added water, these products require fewer preservatives, which means less risk for anyone with sensitivities to common stabilizers. Instead, waterless formulas often use oils, waxes, and butters, which deliver emollients, occlusives, and humectants directly to the skin, precisely what your barrier needs to stay hydrated, strong, and more resistant to everyday irritants. And the minimalist ingredient lists are a bonus: fewer fillers, stabilizers, and emulsifiers, which means what's on your skin is what your skin actually needs. Not all actives work without water. Certain peptides or vitamin C derivatives still require a liquid carrier, but most of your barrier-supporting staples (ceramides, squalane, plant butters)are perfect for this new format. For anyone dealing with eczema, rosacea, or just unpredictable irritation, solid skincare offers a clear advantage. As dermatologist Dr. Hadley King, MD, FAAD explains, 'Water-based products often require preservatives to prevent microbial growth. This can be minimized in waterless formulations, which is helpful for those with sensitivities to topical preservatives.' The benefits don't end there. Waterless and solid bars are typically rich in lipids and fatty acids, think shea butter, coconut oil, and nourishing plant waxes. These support the skin barrier by restoring the natural lipid layer and locking in hydration, crucial for those over 30 whose skin may not bounce back from dehydration as quickly as it once did. Dr. King notes that when it comes to shampoos, solid bars like Ethique's Scalp Health Shampoo Bar now use oatmeal, karanja oil, and neem seed oil to calm inflammation without the drying detergents of traditional soap. And what about the myth that solid bars are drying or harsh? It's a relic of old-school soaps, Dr. King says: 'Most solid cleansers and balms today are rich in emollients, use gentle surfactants, and support the skin barrier every bit as well as liquids.' Waterless products also don't disrupt the skin's pH as much, since pH is only measured in water-based formulas. By leaving the skin's naturally acidic environment undisturbed, they help preserve a balanced microbiome, which is your first line of defense against irritation and inflammation. A key reason solid skincare has taken off in the wellness world? Ingredient potency. With no water to dilute the actives, you're getting more of what works. Products will last longer and are more shelf-stable, perfect for frequent flyers or anyone tired of tossing expired creams. For those who worry about texture, absorption, or cost: oil-based solids can sometimes feel heavier and take longer to soak in, and waterless products may be pricier up front. But for most wellness-minded adults, the pay-off is real, especially if you've struggled to find a moisturizer that soothes, not stings, or a cleanser that leaves you soft, not stripped. Not every step in your routine needs to be waterless. Some actives truly do their best work dissolved in water, but for daily barrier care, these formulas deliver on both efficacy and experience. Click here to learn more about Dr. Hadley King
